We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+1.91%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.69%
AUM
$1.37B
AUM Growth
-$224M
Cap. Flow
-$309M
Cap. Flow %
-22.53%
Top 10 Hldgs %
17.96%
Holding
216
New
21
Increased
69
Reduced
53
Closed
28

Top Buys

Rank Stock Value
1
DNA icon
Ginkgo Bioworks
DNA
+$29M
2
MXCT icon
MaxCyte
MXCT
+$14.8M
3
SKIN icon
SkinHealth Systems
SKIN
+$8.7M
4
JBTM
JBT Marel
JBTM
+$7.82M
5
EXE
Expand Energy Corp
EXE
+$7.8M

Top Sells

Rank Stock Value
1
ZLAB icon
Zai Lab
ZLAB
+$25.1M
2
INSP icon
Inspire Medical Systems
INSP
+$21.2M
3
TXG icon
10x Genomics
TXG
+$21.1M
4
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$20.2M
5
TRIL
Trillium Therapeutics Inc.
TRIL
+$13.4M

Sector Composition

Rank Sector Weight
1 Healthcare 35.81%
2 Technology 14.81%
3 Financials 9.02%
4 Industrials 8.86%
5 Consumer Discretionary 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KRNT icon
1
Kornit Digital
KRNT
$734M
$31M 2.26%
213,945
+8,278
+4% +$1.09M
BHVN
2
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$28M 2.05%
201,905
-161,803
-44% -$20.2M
DNA icon
3
Ginkgo Bioworks
DNA
$584M
$27.6M 2.01%
+59,532
New +$29M
MPWR icon
4
Monolithic Power Systems
MPWR
$66B
$26.8M 1.96%
55,267
-4,552
-8% -$2.07M
RGEN icon
5
Repligen
RGEN
$8.3B
$25.6M 1.87%
88,621
-48,031
-35% -$12.3M
LSCC icon
6
Lattice Semiconductor
LSCC
$18B
$23.3M 1.7%
360,576
+14,587
+4% +$862K
ITCI
7
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$22.9M 1.67%
613,212
+14,951
+2% +$520K
MRTX
8
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$21.2M 1.55%
120,023
+1,432
+1% +$230K
GTLS
9
DELISTED
Chart Industries
GTLS
$20.2M 1.47%
105,690
+3,136
+3% +$540K
ESTC icon
10
Elastic
ESTC
$7.15B
$19.3M 1.41%
129,796
+4,188
+3% +$644K
AVTR icon
11
Avantor
AVTR
$9.25B
$18.3M 1.34%
447,542
-253,641
-36% -$9.91M
WAL icon
12
Western Alliance Bancorporation
WAL
$9.04B
$17.7M 1.29%
162,824
+33,207
+26% +$3.23M
ARGX icon
13
argenx
ARGX
$52B
$16.7M 1.22%
55,298
-23,229
-30% -$7.36M
WSC icon
14
WillScot Mobile Mini Holdings
WSC
$4.66B
$16.5M 1.2%
520,077
+45,982
+10% +$1.33M
HZNP
15
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$16.2M 1.19%
148,245
-79,594
-35% -$8.26M
TGTX icon
16
TG Therapeutics
TGTX
$7.07B
$16.2M 1.18%
485,838
-175,126
-26% -$5.42M
TFII icon
17
TFI International
TFII
$11.1B
$15.9M 1.16%
155,539
+2,298
+1% +$246K
NEO icon
18
NeoGenomics
NEO
$2.04B
$15.4M 1.12%
318,627
-154,637
-33% -$7.16M
TKNO icon
19
Alpha Teknova
TKNO
$284M
$15.1M 1.1%
604,770
+311,189
+106% +$6.66M
IIPR icon
20
Innovative Industrial Properties
IIPR
$1.7B
$14.9M 1.09%
64,534
+1,856
+3% +$419K
BX icon
21
Blackstone
BX
$108B
$14.9M 1.09%
127,782
+25,931
+25% +$3.01M
ESI icon
22
Element Solutions
ESI
$9.18B
$14.6M 1.07%
674,751
+82,699
+14% +$1.89M
ESTA icon
23
Establishment Labs
ESTA
$2.73B
$14.3M 1.05%
200,370
-34,200
-15% -$2.52M
TWST icon
24
Twist Bioscience
TWST
$6.29B
$14.3M 1.05%
134,062
-48,905
-27% -$5.6M
RRR icon
25
Red Rock Resorts
RRR
$3.84B
$14.3M 1.05%
279,905
+12,209
+5% +$533K
1
2 3 4 5

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Nicholas Investment Partners held 216 positions worth $1.37B, down 14% from $1.59B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Nicholas Investment Partners withdrew a net $309M in Q3 2021, closing 28 positions and reducing 53 holdings. Its most notable exit was Zai Lab, an estimated $25.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 45% a quarter earlier, followed by Technology and Financials.

Against the trend, Nicholas Investment Partners opened a new position in Ginkgo Bioworks worth $27.6M.

  • Nicholas Investment Partners's largest Q3 2021 buy was Ginkgo Bioworks: 59,532 shares worth $27.6M.
  • Nicholas Investment Partners added most to Expand Energy Corp in Q3 2021, an estimated $7.8M increase.
  • Nicholas Investment Partners's biggest Q3 2021 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $20.2M.
  • Nicholas Investment Partners fully exited Zai Lab in Q3 2021, selling an estimated $25.1M.
  • Nicholas Investment Partners's ten largest holdings make up 18% of its $1.37B portfolio in Q3 2021.
  • Nicholas Investment Partners opened 21 new positions and closed 28 in Q3 2021.
  • Nicholas Investment Partners's portfolio value fell 14% quarter-over-quarter to $1.37B.

Based on Nicholas Investment Partners's 13F filing for Q3 2021, filed 15 Nov 2021.